Danaos (NYSE: DAC) CEO linked to 9,538,502 shares via 883 Trust

Rhea-AI Filing Summary

Danaos Corp director and Chief Executive Officer John Coustas filed an initial ownership report showing indirect holdings of 9,538,502 shares of common stock. These shares are held by Danaos Investment Limited as trustee of the 883 Trust for the benefit of Dr. Coustas and his family.

The board of Danaos Investment Limited, whose members are not beneficiaries of the 883 Trust or part of the Coustas family, has voting and dispositive control over these shares. Dr. Coustas disclaims beneficial ownership for Section 16 purposes except to the extent of any pecuniary interest.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Coustas John

Role Chief Executive Officer

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 9,538,502 shares (Indirect, By Danaos Investment Limited as Trustee of the 883 Trust)

Footnotes (1)

1. [object Object]

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Coustas John

(Last) (First) (Middle)

14 AKTI KONDYLI

(Street)

185 45 PIRAEUS 00000

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Danaos Corp [ DAC ]

3a. Foreign Trading Symbol
[N/A]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	9,538,502	I	By Danaos Investment Limited as Trustee of the 883 Trust(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares held indirectly through Danaos Investment Limited ("DIL") as Trustee of the 883 Trust. The beneficiaries of the 883 Trust are Dr. Coustas and members of his family. The board of directors of DIL consists of five members, none of whom are beneficiaries of the 883 Trust or members of the Coustas family, and has voting and dispositive control over the shares held by the 883 Trust. Dr. Coustas has certain powers to remove and replace DIL as trustee of the 883 Trust. Dr. Coustas disclaims beneficial ownership of such shares purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that Dr. Coustas is a beneficial owner of the shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Evangelos Politis, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does John Coustas report owning in Danaos Corp (DAC) on this Form 3?

John Coustas reports indirect ownership of 9,538,502 Danaos Corp common shares. The shares are held through Danaos Investment Limited as trustee of the 883 Trust, which benefits Dr. Coustas and his family but is controlled by an independent board.

How are the 9,538,502 Danaos Corp (DAC) shares held for John Coustas?

The 9,538,502 shares are held indirectly via Danaos Investment Limited as trustee of the 883 Trust. Danaos Investment Limited’s five-member board, none related to the Coustas family, has voting and dispositive power over these shares on behalf of the trust.

Does John Coustas have voting control over the reported Danaos (DAC) shares?

Voting and dispositive control rests with Danaos Investment Limited’s board, not John Coustas. The board members are not beneficiaries of the 883 Trust or Coustas family members, though Dr. Coustas can remove and replace the trustee under certain powers.

Does John Coustas disclaim beneficial ownership of his indirect Danaos (DAC) shares?

Yes, Dr. Coustas disclaims beneficial ownership for Section 16 purposes except for any pecuniary interest. The filing states it should not be deemed an admission that he is a beneficial owner of the shares under the Exchange Act.

What is the role of the 883 Trust in John Coustas’s Danaos (DAC) holdings?

The 883 Trust is the beneficial vehicle through which 9,538,502 shares are held. Danaos Investment Limited acts as trustee, with its independent board controlling the shares for the benefit of Dr. Coustas and his family members.

Is this Danaos (DAC) filing reporting a new transaction by John Coustas?

No specific buy or sell transaction is reported; this is an initial ownership statement. The entry reflects indirect holdings of 9,538,502 common shares held through a trust structure rather than detailing a recent trade.